Navigating Prescription Dosage Adjustments
I’m a 20-year-old female diagnosed with ADHD, currently prescribed a daily dose of 37.5 mg of extended-release dextroamphetamine-amphetamine, in addition to a birth control pill that I have used for a couple of years. **Overview:** Ten days ago, I collected a refill of my prescribed stimulant, yet it appears that my tolerance has risen, or perhaps this medication is no longer effective for my needs. Unfortunately, I cannot consult my typical general practitioner since she recently relocated overseas with her military partner, and my usual clinic is two hours away, making it challenging to visit without transportation. My question is whether I can find a local GP to obtain a different prescription (likely reverting to regular amphetamine salts with an adjusted dosage) or if the pharmacy or doctor might deny this request due to my recent refill. Stimulants are crucial for managing my ADHD and contributing to my academic success. Since beginning treatment, my life quality has noticeably improved; I elevated my GPA from a 2.0 to achieving a spot on the dean's list last semester. Now, I can focus more on school without excessive stress, allowing me more time for extracurricular activities, socializing, and my part-time job. Starting stimulants in January 2025 represented a significant shift for me, offering almost no side effects aside from the expected loss of appetite (I've been losing weight healthily, down from 70 pounds overweight) and considerable tiredness as the medication wore off. I have experienced no blood pressure concerns. I do not struggle with depression or anxiety. Despite feeling extreme fatigue when not medicated, I maintain a positive outlook and lack any feelings of hopelessness or suicidal thoughts. My life feels fulfilling, and I look forward to what lies ahead. However, the upcoming weeks until I can connect with a new doctor are likely to be challenging if I cannot resolve my current situation. Although I have experienced anxiety in response to a specific trigger, which is overwhelming and debilitating, I don’t generally feel this distress when facing routine stresses. I tend to ignore my issues, preferring to proceed with my day as if they don’t exist. Currently, my prescription is failing to deliver desired results. I’m encountering the same attention and work-related challenges I faced prior to initiating medication. Five weeks into this semester, I find myself falling behind again, which affects my sleep and adds considerable stress. I recognize that continually increasing stimulant doses isn't a sustainable long-term solution and is not beneficial. I am aware that seeking a euphoric high is unhealthy; when I say it’s ‘not working,’ I refer specifically to my engagement in academic settings and during homework. When dosage levels were optimized in the previous semester, I remained engaged in class, avoiding nail-biting and restlessness, and could complete assignments well before they were due without the compulsion to check my phone. I typically felt wholly like myself under the right dosage, which remains my aim with these medications. On days I attempt to skip a dose but end up taking one, it’s not due to addiction—just pure exhaustion preventing me from functioning. I recognize when I’ve exceeded my limits, such as times I’ve taken two pills while cramming for finals. While focusing is possible, it often leaves me with painful sores inside my mouth. I fully understand the sensations associated with taking too little or too much medication, and right now, I’m definitely underdosing. I began taking dextroamphetamine because of how drowsy I became in the afternoons when the effects of my extended-release amphetamine began to wane. Since my early classes start at 8 a.m., by evening, I could barely keep my eyes open. I aim to incorporate a non-stimulant ADHD treatment beginning in October to assist on days when a break from stimulants is necessary. For now, managing extreme evening drowsiness is preferable to failing classes. With a current GPA of 2.7 and five semesters remaining, it's vital I maximize my performance in each course to get back on track. It's incredibly frustrating to find myself needing to adjust my dosage so frequently, as medications seem to lose their effectiveness far too rapidly. Although I know that taking breaks or skipping weekends can be beneficial, if I miss a single day of medication, I feel utterly depleted and ineffective, a situation that worsens with each subsequent day off. I strive to get ahead to maintain some days without medication but often find that I can’t afford to be unproductive two days a week. My workload does not seem unreasonable: I’m enrolled in 14 credit hours, work part-time as a resident advisor (3 to 7 hours weekly), commit to a 4-hour per week TA job, and participate in research, which is flexible (around 4 hours weekly). I know I am capable of managing this workload, as evidenced by consistently earning A’s and B’s when properly medicated or when I had external motivation like parental support in high school. I know I can achieve academically—the current barrier is proper medication facilitating normal focus. I’ve noticed a rapid build-up of tolerance to amphetamine salts, moving from 10 mg to 20 mg within a month and then increasing from 20 mg to 25 mg over three months, after which the 25 mg seemed ineffective after another three months. I'm uncertain whether my recent prescription is failing due to a tolerance issue (having recently shifted from 25 mg dextroamphetamine to 37.5 mg only a month ago) or if the change in medication type is at fault. Clearly, a change is necessary, but with my old office located two hours away and inaccessible due to my lack of transport—with my previous doctor having moved out of the country recently—attending an appointment proves difficult. My clinic has facilitated a different doctor to fill my prescription received ten days ago, but any adjustment requires an in-person visit, as telehealth is not offered. Even if I could see my former doctor, would the pharmacy permit me to fill a different prescription so soon after receiving my last? It's evident that my current medication isn’t effective, and I shouldn’t have to continue taking something that doesn’t meet my needs. However, stimulants cannot be refilled just a few days early. Any advice on how to navigate this would be greatly appreciated!
Answers (1)
9/15/2025, 2:41:20 PM
OpenHealth AI
It sounds frustrating to feel that your medication for ADHD isn't providing the support it once did, especially given the positive impact it has had on your life and academic performance. Here are some main points to consider moving forward:
-
Understanding the Challenge: Tolerance to stimulants can develop quickly, leading to decreased effectiveness in managing ADHD symptoms. Changes in your medication may be necessary to regain control over your focus and productivity.
-
Temporary Solutions: While awaiting a consultation with a new physician, there are strategies you can employ to manage your symptoms.
Explanation:
Stimulant medications, like dextroamphetamine, can become less effective over time as your body adjusts to them. It's essential to approach this situation cautiously, as any changes in medication need to be managed under a doctor's guidance. However, your immediate need for medication adjustment is understandable given the impact on your school performance and overall well-being.
Next Steps:
-
Visit a Local Provider: Seek out a local healthcare provider who can see you for an evaluation. They might be able to prescribe a different stimulant or adjust your dosage if they agree on the necessity based on your history.
-
Document Your Experience: Keep a detailed record of your medication history, dosages that have worked previously, your current symptoms, and any side effects. This information will help a new physician quickly understand your situation.
-
Communicate with the Pharmacy: Speak with your current pharmacy about your challenges. While they generally cannot fill a new prescription too soon, they might be able to provide guidance or work with the new provider to reassess the situation.
-
Consider Lifestyle Adjustments: Focus on maintaining a healthy routine that includes:
- Sleep management: Aim for consistent sleep patterns to help mitigate fatigue.
- Nutrition: Ensure you are eating balanced meals to maintain energy levels, especially given the decreased appetite.
- Stress management: Techniques such as mindfulness, deep breathing exercises, and physical activities can reduce overall stress and improve focus.
-
Explore Non-Stimulant Options: If possible, research non-stimulant ADHD treatments that you can discuss with your new doctor. If you plan to incorporate these in October, having a conversation and preparing beforehand may be beneficial.
-
Stay Engaged: Reach out to your academic resources, such as counseling services or ADHD support groups, that may offer strategies or support during this time.
-
Create an Action Plan: Prioritize your academic workload to manage challenges while you seek medication adjustments. Break tasks into smaller, manageable parts and set deadlines to keep yourself organized.
By taking these actions, you can begin to manage your current symptoms while working towards a better medication strategy. Remember, your well-being and academic success are achievable, and there are steps you can take to get back on track. Let me know if you need any further assistance or guidance!
Related Questions
Understanding Atrial Fibrillation and Thyroid Issues: Variability in Cardioversion Decisions
Hello everyone, I’m reaching out for guidance regarding my mother’s current health situation, and I’d greatly appreciate any shared experiences or thoughts. **My mother's background:** - **Age**: 55 years - **Weight**: Recently dropped to 116 kg from 118 kg in just two days, likely due to diuretics. - **Health history**: Previously an underactive thyroid, undiagnosed and untreated, now presenting as overactive. - **Medications**: Currently taking thyroid medication and a beta-blocker (Rapiblock). **Current health status:** My mother has been hospitalized since Tuesday, experiencing **atrial fibrillation with heart rates exceeding 200** beats per minute due to her thyroid's hyperactivity. - The plan for cardioversion was initially settled on Tuesday. However, the following day, the medical team advised postponing it until her thyroid levels could be stabilized, believing that her heart rate would return to normal once her thyroid condition was managed. - Her **obesity** precludes her from undergoing a transthoracic echocardiogram, and due to her thyroid concerns, she cannot handle contrast dye (this has been a consistent issue for over four years). Therefore, the only feasible option was a **transesophageal echocardiogram (TEE)**, which has yet to be performed. - She has been prescribed various medications including beta-blockers and thyroid treatments in the past. - On Friday, a doctor proposed proceeding with cardioversion; however, the attending senior physician objected. - Today (Saturday), another clinician has expressed a desire to move forward with cardioversion, having initiated a new medication, as the senior physician is unavailable. - **Communication has been unclear**, as we were notified of developments by a nurse rather than the physician in charge, causing confusion and anxiety. - Currently, only a **chest X-ray** is scheduled, and the TEE remains unaddressed. **My inquiries are as follows:** 1. Is it common for medical professionals to have varying opinions and frequently revise medication or treatment plans like cardioversion? 2. Is it safe to conduct cardioversion in the absence of a TEE? I presumed that this was a standard procedure to exclude the presence of blood clots. 3. Is it usual practice to have only a chest X-ray prior to moving ahead with cardioversion? 4. How typical is it for patients or their families to not be directly informed about treatment changes and learn about them through nursing staff instead? I recognize that this cannot substitute for professional medical advice. I’m simply trying to discern whether these circumstances are typical or if we should express our concerns more assertively with the healthcare facility. Thank you for your insights!
28-Year-Old Male Experiencing Scalp Sensations Post-Amitriptyline Treatment
I am a 28-year-old man in generally good health, without any cardiac concerns. Approximately a month ago, I encountered intense pain localized to one side of my head, which was unresponsive to paracetamol. However, a single dose of a migraine treatment provided substantial relief. Following that, I began a regimen of amitriptyline, starting at a nightly dose of 10 to 25 mg. While my head pain has diminished significantly—by about 90 to 95%—I now experience occasional uncomfortable sensations on my scalp. These feelings include pins and needles, a cooling sensation, and some crawling feelings near my hairline and ears. There are fleeting moments where I feel brief throbs lasting a second, but I do not have any persistent headaches. To clarify, I do not experience any of the following: - Nausea - Weakness in my limbs - Numbness - Changes in my vision - Coordination difficulties - Seizures The symptoms I have are transient, shifting around and often intensifying when I become conscious of them or as the day progresses. I would like to know: Is it common to experience these sensations during the recovery stage following episodes of neuralgia or migraine-like discomfort? Additionally, could the amitriptyline potentially be causing these temporary paresthetic sensations? I am seeking some reassurance or advice on what is typically observed during this healing process. Thank you.
Concerns About My Toes
Age: 30, Female Currently, I am on the lookout for a reputable podiatrist in my vicinity. However, I've encountered a perplexing issue with my foot. Just last night, I noticed a growth on the side of my toe, something entirely new to me. I maintain a nutritious diet and have a demanding job that requires me to be on my feet quite often. My footwear includes brands such as Brooks Ghost Runners, Hoka Bondi 9’s, and Nike Motiva’s, and I don’t opt for restrictive socks. I also apply Vick’s Vaporub to my feet, a practice handed down from my family, and stick with simple, non-fragrant lotions like Vanicream and CeraVe SA Cream for my skin. In addition, I am curious about the my big toenail's change in color. What might be the underlying reasons for this? Also, I have these persistent dark spots on my toes that I've struggled with since my days on the runway. Despite my efforts, nothing has succeeded in lightening or diminishing their appearance. I'm just looking to determine if there might have been a factor from the past that could have contributed to these issues. I’m not sure what else to include, but I’m open to answering any questions you might have. Thank you for your attention! Best wishes from a worried soul!
7-Month-Old Child with Abernethy Malformation - Exploring Treatment Options
# 7-Month-Old Child with Abernethy Malformation - Exploring Treatment Options ## [7-Month-Old] Identified with Abernethy Malformation (Congenital Portosystemic Shunt) - Treatment Methods? **Age:** 7 months **Gender:** Female **Height:** Age-appropriate **Weight:** Currently 9 kg, was 2.8 kg at birth **Ethnicity:** Asian **Duration of Symptoms:** Present since birth **Location:** Uzbekistan **Pre-existing Health Issues:** Abernethy malformation (congenital portosystemic shunt), liver hemangiomas, chronic jaundice, anemia **Current Treatments:** Supportive management --- ## INITIAL PRESENTATION (June 2025 - July 2025) Our daughter arrived on **June 27, 2025**, presenting with: - Birth weight: **2.8 kg** - Marked jaundice (yellowing of skin and sclera) - Pale or clay-colored stools - **Bilirubin level: 245 μmol/L** (typically <20) An immediate ultrasound indicated multiple liver anomalies, initially thought to be hemangiomas. --- ## FIRST COMPREHENSIVE ASSESSMENT (August 1, 2025 - 1 Month Old) ### Multislice Computed Tomography (MSCT) with 3-Phase Contrast (August 1, 2025): **RESULTS:** - **Portocaval shunt size: 9.9 mm** (blood bypassing the liver into the inferior vena cava) - **Arteriovenous shunt size: 4.4 mm** - **Portal vein size: 6.1 mm** (patent) - **Three nodular cystic lesions** located in the perivascular area, with largest measuring 11.6×20.7 mm, enhancing during the venous phase - Liver features a heterogeneous architecture, exhibiting irregular enhancement - Gallbladder appears elongated and slightly enlarged - Other abdominal organs exhibit normal findings **RADIOLOGIST’S ASSESSMENT:** "Congenital portosystemic shunt indicative of Abernethy malformation; less likely arteriovenous malformation (AVM); cannot dismiss the possibility of localized liver lesions." **ADVICE:** Seek consultations with an abdominal and vascular surgeon. ### Blood Tests (August 1, 2025): **Complete Blood Count:** - WBC: 10.44 × 10⁹/L (normal range) - **RBC: 2.1 × 10¹²/L** (LOW - indicating severe anemia) - **Hemoglobin: 69 g/L** (CRITICALLY LOW; normal is 117-166) - Platelets: 403 × 10⁹/L (elevated) **Biochemistry Analysis:** - Urea: 1.80 mmol/L (normal) - Creatinine: 33.4 μmol/L (normal) - **ALT: >1000 IU/mL** (EXTREMELY HIGH - severe liver dysfunction) --- ## FOLLOW-UP IMAGING (December 16, 2025 - 5.5 Months Old) ### Liver Ultrasound: **RESULTS:** - Right lobe: 64 mm, left lobe: 43 mm - Liver capsule appears irregular and vague - **Parenchyma: heterogeneous, showing 7 hypo-isoechoic nodules** (sizes range from 11.5×10.7 mm to 17.6×15.4 mm) - Capsule features uneven contours - Blood flow noted during Doppler examination - No dilation in intrahepatic bile ducts - **Portal vein: 3.9 mm** (decreased from 6.1 mm - indicating improvement) - Common bile duct: 1.4 mm - Gallbladder: measures 43.7×9.2 mm (pear-shaped, wall thickness 2.0 mm, homogeneous, free of stones) **ULTRASOUND ASSESSMENT:** "Presence of liver volumetric formations (specifically liver hemangiomas)." --- ## LATEST MSCT (February 6, 2026 - 7 Months Old) ### MSCT with 3-Phase Contrast: **FINDINGS:** - Liver remains normal in size, but shows heterogeneous structure with uneven contrast enhancement - **Portocaval shunt: 9.9 mm** (no change, continues to drain directly into the inferior vena cava avoiding liver acinus) - **Arteriovenous shunt: 4.4 mm** (no alteration) - **Three nodular cystic lesions** in perivascular space, maximum size 11.6×20.7 mm, enhancing in the venous phase - **Portal vein: 6.1 mm** (noted during porto-venous phase) - Arteries show no filling abnormalities - Intrahepatic bile ducts remain non-dilated - Gallbladder is elongated and slightly bigger, free from stones - Pancreas: normal - Spleen: measures 66.9×38.5 mm (not enlarged), splenic vein is 3.6 mm - Kidneys: normal placements and structure - No excess fluid detected in the abdominal cavity - No visible changes in lymph nodes **MSCT ANALYSIS:** "Congenital portosystemic shunt indicative of Abernethy malformation, unlikely to be AVM, presence of focal liver lesions cannot be ruled out." **RECOMMENDATION:** Engage with an abdominal and vascular surgeon. --- ## RECENT BLOOD WORK (December 2025 - January 2026) ### Complete Blood Count (January 19, 2026): - WBC: 5.8 × 10⁹/L (SHOWS IMPROVEMENT) - **RBC: 2.93 × 10¹²/L** (IMPROVED but still low) - **Hemoglobin: 72 g/L** (SHOWS IMPROVEMENT but still low) - Platelets: 223 × 10⁹/L (BACK TO NORMAL) - Neutrophils: 30.0% - Lymphocytes: 64.8% - Monocytes: 4.6% ### Biochemistry (January 28, 2026): - Total protein level: 67 g/L (slightly deficient) - Creatinine: 20.7 μmol/L - **Total Bilirubin: 242 μmol/L** (STILL HIGH - unchanged) - **Direct Bilirubin: 142 μmol/L** (VERY HIGH) - **ALT: 50 IU/mL** (DRASTICALLY LOWER from >1000!) --- ## OVERVIEW OF PROGRESS OVER 6 MONTHS | Parameter | August 2025 | January 2026 | Change | |------------------|-------------|---------------|--------------------------| | **Hemoglobin** | 69 g/L | 72 g/L | ↗ Slight improvement | | **RBC** | 2.1 | 2.93 | ↗ Improved | | **ALT** | >1000 | 50 | ✓✓ MAJOR IMPROVEMENT | | **Bilirubin** | 245 | 242 | → Unchanged (still elevated) | | **Portal vein** | 6.1 mm | 3.9 mm (US) | ↗ Decreased | | **Platelets** | 403 | 223 | ↘ Normalized | | **Shunt size** | 9.9 mm | 9.9 mm | → No Change | --- ## CURRENT SITUATION (February 2026 - 7 Months Old) - **Weight:** 9 kg (good growth rate in spite of condition) - **Jaundice:** Continues to be present (yellow skin) - **Stools:** Remain pale/clay-colored - **Development:** Achieving appropriate milestones - **Energy:** Appears to have a good energy level - **Feeding:** Normal appetite --- ## QUESTIONS FOR r/AskDocs We have been informed this is **Type 2 Abernethy malformation** (portal vein present). **Three treatment avenues have been proposed:** ### Option 1: **Endovascular Coil Embolization** (minimally invasive approach) - A catheter is inserted via the leg vein to access the shunt and deploy coils/plugs to close the abnormal vessels - Pros: No surgical incision, minimal discomfort, short hospital stay (2-4 days), no scars, enhanced safety - Duration: 1-2 hours - Recovery: 2-4 weeks for jaundice to show improvement ### Option 2: **Open Surgical Intervention** - An incision in the abdomen to ligate abnormal vessels and redirect blood to the liver - Pros: Direct visualization, effective results - Cons: Surgical scar, longer recovery time (7-14 days in hospital) - Duration: 2-4 hours ### Option 3: **Liver Transplantation** - We have been advised this is not necessary as the portal vein is functional and liver health is improving. --- ## SPECIFIC QUESTIONS TO CONSIDER: 1. **With a functional portal vein (6.1 mm) and improving liver function (ALT normalized), is it advisable to pursue endovascular closure as the preferred treatment?** 2. **Despite ALT levels improving, the bilirubin remains consistently high (242). Should this be a cause for concern? Is there a prospect for it to normalize post shunt closure?** 3. **Are the hemangiomas/nodules (11.6×20.7 mm) linked to the shunt? Will they likely resolve following shunt repair?** 4. **How urgent is the proposed intervention? Is immediate action required, or is there flexibility to wait a few months?** 5. **What complications should we be vigilant for during the waiting period?** 6. **Regarding endovascular closure - what is the average success rate for infants aged 7 months? Are there concerns regarding the shunt size (9.9 mm)?** 7. **The measurement of the portal vein has shown improvement from 6.1 mm to 3.9 mm; should this be perceived as a positive sign or a reason for concern?** 8. **Are there special directives (diet modifications, medications) we should consider while awaiting the procedure?** 9. **Post-procedure, how long should we expect it might take for:** - Normalization of bilirubin levels? - Return of stool color to normal? - Resolution of jaundice? - Regression of hemangiomas? 10. **Can you recommend any specialized centers for pediatric Abernethy malformation treatments? We are located in Uzbekistan but are prepared to travel (to Turkey, Russia, South Korea, etc.)** --- ## ADDITIONAL INFORMATION - No family history of hepatic diseases - Pregnancy and delivery were normal - No additional congenital defects identified - Immunizations up to date - No history of bleeding disorders - No signs indicative of encephalopathy - Child is alert and engaged --- **I can supply actual MSCT images and comprehensive lab reports if they would be of assistance.** We sincerely appreciate any insights you can provide. We are striving to make the most informed decision regarding our daughter’s care and highly value expert medical opinions. **TL;DR:** 7-month-old diagnosed with Abernethy Type 2 malformation (9.9 mm portocaval shunt, patent portal vein). Liver functionality is improving (normalized ALT) while bilirubin remains elevated (242). Evaluating options between endovascular coil embolization and open surgery. Seeking expert advice on optimal treatment strategy and timing.
Strange Jelly-Like Substance Observed from Wound
I’m a 21-year-old female living with an auto-inflammatory condition known as hidradenitis suppurativa (HS). Recently, I've experienced a concerning issue with one of my wounds. This particular wound causes significant pain and excessive bleeding. However, whenever I attend to it, I tend to find this unusual jelly-like substance present within it. Interestingly, this phenomenon has only occurred with this one wound and not any of the others I have. The bleeding seems to persist until I manage to remove this jelly substance, after which it typically slows down and comes to a halt completely. I’m seeking insights into what this might signify so that I can effectively discuss it with my healthcare provider.